# Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer

> **NCT00003642** · PHASE2 · TERMINATED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 43 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** fluorouracil
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00003642
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1998-10
- **Primary completion:** 2001-07
- **Final completion:** —
- **Target enrollment:** 43 (ESTIMATED)
- **Why stopped:** low accrual
- **Last updated:** 2012-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003642, "Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00003642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*